The Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China
Location status: Recruiting
NCT Number: NCT07760038
The goal of this study is to find out whether phycocyanin, a natural protein from spirulina, can help protect the liver and support recovery in adults having part of their liver removed. The study will also look at whether phycocyanin is safe to take.The main questions are:
Does phycocyanin reduce liver injury after surgery? Does it help the liver grow back and recover? What side effects or medical problems happen while taking it?
Researchers will compare phycocyanin with a placebo, which looks similar but does not contain phycocyanin. About 30 people will take part. Each person will be randomly placed into one of the two groups, and neither the participants nor the researchers will know which treatment each person receives during the study.
Participants will:
Take 1.5 grams of phycocyanin or placebo every day for 3 weeks before surgery and 3 weeks after surgery Receive the usual care for liver surgery Give blood and stool samples before and after treatment Allow researchers to study a small piece of liver tissue removed during surgery Return for follow-up for up to 90 days after surgery
The samples will be used to check liver function, inflammation, gut bacteria, and changes linked to liver healing. Possible side effects include an allergic reaction or stomach discomfort. The study has been approved by an ethics committee.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will take 1.5 grams of phycocyanin by mouth once daily for 3 weeks before partial hepatectomy and for 3 weeks after surgery. Phycocyanin is a natural protein from spirulina.
Participants will take 1.5 grams of maltodextrin placebo by mouth once daily for 3 weeks before partial hepatectomy and for 3 weeks after surgery. The placebo does not contain phycocyanin.
Time frame: Baseline and Week 3 after surgery
Time frame: Baseline and Week 3 after surgery
Time frame: Baseline and Week 3 after surgery
Time frame: Baseline and Week 3 after surgery
Time frame: Baseline and Week 3 after surgery
Time frame: Baseline and Week 3 after surgery
Time frame: through study completion, an average of 1 year
Contact information is provided by the study sponsor or research team.
Second Affiliated Hospital, Zhejiang University, School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05286814
Adenocarcinoma, Adrenal Cortex Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07632235
Adenocarcinoma, Carcinoma
Shanghai, China
View Trial DetailsNCT06925516
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial DetailsNCT07640048
Adenocarcinoma, Carcinoma
Beijing, China
View Trial Details